Ignite Creation Date:
2024-05-05 @ 9:17 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00856921
Status:
COMPLETED
Last Update Posted:
2009-03-06
First Post:
2009-03-05
Brief Title:
Genetic Evaluation of AAAS Gene in Early-Onset Achalasia and Alacrima Patients
Sponsor:
Asan Medical Center
Organization:
Asan Medical Center
Study Overview
Official Title:
To Find Out the Genetic Relationship Between the Early-Onset Achalasia and AAAS Gene
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AAAS
Brief Summary:
The AAAS gene has been known to cause achalasia alacrima adrenal abnormalities and a progressive neurological syndrome A considerable proportion of achalasia patients have been known to show alacrima decreased secretion of tears However the genetic mechanism between achalasia and alacrima has not been defined yet The investigators postulated that some proportions of early-onset achalasia could be correlated with AAAS gene thus the investigators aimed to investigate the relationship between the AAAS gene and early-onset achalasia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None